On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer

BACKGROUND: Neoadjuvant chemotherapy is increasingly given preoperatively to shrink breast tumours prior to surgery. This approach also provides the opportunity to study the molecular changes associated with treatment and evaluate whether on-treatment sequential samples can improve response and outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bownes, Richard J., Turnbull, Arran K., Martinez-Perez, Carlos, Cameron, David A., Sims, Andrew H., Oikonomidou, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570893/
https://www.ncbi.nlm.nih.gov/pubmed/31200764
http://dx.doi.org/10.1186/s13058-019-1159-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570893/
https://www.ncbi.nlm.nih.gov/pubmed/31200764
http://dx.doi.org/10.1186/s13058-019-1159-3

Ejemplares similares